Loading...

APC/Cyanine7 anti-mouse CD8a Antibody APC/Cyanine7 anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
  • 53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
    C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100714 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100713 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  2. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  3. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  4. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  5. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  6. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  7. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  8. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  9. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  10. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  11. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  12. Ke F, et al. 2023. Elife. 12:. PubMed
  13. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  14. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  15. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  16. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  17. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  18. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  19. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  20. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  21. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  22. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  23. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  24. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  25. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  26. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  27. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  28. Qu L, et al. 2022. Cell. 185:1728. PubMed
  29. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  30. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  31. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  32. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  33. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  34. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  35. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  36. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  37. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  38. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  39. Elazar A, et al. 2022. Elife. 11:. PubMed
  40. Berube A, et al. 2022. Viruses. 14:. PubMed
  41. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  42. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  43. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  44. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  45. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  46. Chen J, et al. 2008. Blood. 111:5163. PubMed
  47. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  48. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  49. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  50. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  51. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  52. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  53. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  54. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  55. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  56. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  57. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  58. Wei H, et al. 2021. Malar J. 20:89. PubMed
  59. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  60. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  61. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  62. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  63. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  64. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  65. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  66. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  67. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  68. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  69. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  70. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  71. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  72. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  73. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  74. Das S, et al. 2019. Oncogene. 383316. PubMed
  75. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  76. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  79. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  80. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  81. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  82. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  83. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  84. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  85. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  86. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  87. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  88. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  89. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  90. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  91. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  92. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  93. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  94. Marangoni F, et al. 2021. Cell. . PubMed
  95. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  96. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  97. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  98. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  99. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  100. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  101. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  102. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  103. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  104. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  105. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  106. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  107. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  108. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  109. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  110. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  111. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  112. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  113. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  114. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  115. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  116. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  117. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  118. Zheng J, et al. 2020. bioRxiv. . PubMed
  119. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  120. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  121. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  122. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  123. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  124. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  125. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  126. França TT, et al. 2021. JCI Insight. 6:. PubMed
  127. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  128. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  129. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  130. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  131. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  132. Zheng J, et al. 2020. Nature. . PubMed
  133. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  134. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  135. Gough D, et al. 2014. Blood. 124:2252. PubMed
  136. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  137. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  138. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  139. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  140. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  141. Giampazolias E, et al. 2021. Cell. . PubMed
  142. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  143. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  144. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  145. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  146. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  147. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  148. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  149. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  150. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  151. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  152. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  153. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  154. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  155. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  156. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  157. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  158. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  159. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  160. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  161. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  162. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  163. Koide S, et al. 2022. iScience. 25:103603. PubMed
  164. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  165. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  166. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  167. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  168. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  169. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  170. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  171. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  172. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  173. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  174. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  175. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  176. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  177. Li H, et al. 2022. iScience. 25:104481. PubMed
  178. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  179. Zhang B, et al. 2021. Nature. 599:471. PubMed
  180. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  181. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  182. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  183. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  184. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  185. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  186. Yang H, et al. 2022. Viruses. 14:. PubMed
  187. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  188. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  189. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  190. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  191. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  192. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  193. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  194. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  195. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  196. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  197. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  198. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  199. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  200. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  201. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  202. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  203. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  204. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  205. Ke F, et al. 2023. Elife. 12:. PubMed
  206. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  207. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  208. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  209. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  210. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  211. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  212. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  213. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  214. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  215. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  216. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  217. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  218. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  219. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  220. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  221. Qu L, et al. 2022. Cell. 185:1728. PubMed
  222. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  223. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  224. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  225. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  226. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  227. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  228. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  229. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  230. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  231. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  232. Elazar A, et al. 2022. Elife. 11:. PubMed
  233. Berube A, et al. 2022. Viruses. 14:. PubMed
  234. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  235. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  236. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  237. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  238. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  239. Chen J, et al. 2008. Blood. 111:5163. PubMed
  240. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  241. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  242. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  243. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  244. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  245. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  246. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  247. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  248. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  249. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  250. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  251. Wei H, et al. 2021. Malar J. 20:89. PubMed
  252. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  253. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  254. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  255. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  256. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  257. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  258. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  259. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  260. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  261. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  262. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  263. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  264. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  265. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  266. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  267. Das S, et al. 2019. Oncogene. 383316. PubMed
  268. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  269. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  270. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  271. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  272. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  273. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  274. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  275. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  276. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  277. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  278. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  279. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  280. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  281. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  282. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  283. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  284. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  285. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  286. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  287. Marangoni F, et al. 2021. Cell. . PubMed
  288. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  289. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  290. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  291. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  292. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  293. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  294. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  295. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  296. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  297. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  298. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  299. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  300. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  301. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  302. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  303. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  304. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  305. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  306. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  307. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  308. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  309. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  310. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  311. Zheng J, et al. 2020. bioRxiv. . PubMed
  312. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  313. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  314. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  315. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  316. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  317. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  318. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  319. França TT, et al. 2021. JCI Insight. 6:. PubMed
  320. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  321. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  322. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  323. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  324. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  325. Zheng J, et al. 2020. Nature. . PubMed
  326. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  327. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  328. Gough D, et al. 2014. Blood. 124:2252. PubMed
  329. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  330. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  331. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  332. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  333. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  334. Giampazolias E, et al. 2021. Cell. . PubMed
  335. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  336. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  337. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  338. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  339. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  340. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  341. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  342. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  343. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  344. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  345. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  346. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  347. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  348. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  349. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  350. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  351. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  352. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  353. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  354. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  355. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  356. Koide S, et al. 2022. iScience. 25:103603. PubMed
  357. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  358. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  359. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  360. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  361. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  362. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  363. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  364. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  365. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  366. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  367. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  368. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  369. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  370. Li H, et al. 2022. iScience. 25:104481. PubMed
  371. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  372. Zhang B, et al. 2021. Nature. 599:471. PubMed
  373. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  374. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  375. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  376. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  377. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  378. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  379. Yang H, et al. 2022. Viruses. 14:. PubMed
  380. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  381. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  382. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  383. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  384. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  385. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  386. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
RRID
AB_312753 (BioLegend Cat. No. 100714)
AB_312752 (BioLegend Cat. No. 100713)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 3    Revision Date: 01.30.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
  • 53-6dot7_APCCyanine7_CD8_Antibody_013019_updated.png
    C57BL/6 mouse splenocytes were stained with CD3 FITC and CD8 (clone 53-6.7) APC/Cyanine7 (left) or Rat IgG2a, κ APC/Cyanine7 isotype control (right).
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
100714 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100713 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  2. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  3. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  4. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  5. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  6. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  7. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  8. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  9. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  10. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  11. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  12. Ke F, et al. 2023. Elife. 12:. PubMed
  13. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  14. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  15. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  16. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  17. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  18. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  19. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  20. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  21. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  22. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  23. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  24. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  25. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  26. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  27. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  28. Qu L, et al. 2022. Cell. 185:1728. PubMed
  29. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  30. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  31. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  32. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  33. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  34. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  35. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  36. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  37. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  38. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  39. Elazar A, et al. 2022. Elife. 11:. PubMed
  40. Berube A, et al. 2022. Viruses. 14:. PubMed
  41. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  42. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  43. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  44. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  45. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  46. Chen J, et al. 2008. Blood. 111:5163. PubMed
  47. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  48. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  49. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  50. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  51. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  52. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  53. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  54. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  55. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  56. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  57. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  58. Wei H, et al. 2021. Malar J. 20:89. PubMed
  59. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  60. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  61. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  62. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  63. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  64. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  65. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  66. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  67. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  68. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  69. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  70. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  71. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  72. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  73. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  74. Das S, et al. 2019. Oncogene. 383316. PubMed
  75. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  76. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  79. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  80. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  81. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  82. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  83. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  84. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  85. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  86. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  87. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  88. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  89. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  90. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  91. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  92. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  93. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  94. Marangoni F, et al. 2021. Cell. . PubMed
  95. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  96. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  97. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  98. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  99. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  100. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  101. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  102. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  103. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  104. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  105. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  106. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  107. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  108. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  109. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  110. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  111. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  112. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  113. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  114. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  115. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  116. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  117. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  118. Zheng J, et al. 2020. bioRxiv. . PubMed
  119. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  120. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  121. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  122. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  123. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  124. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  125. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  126. França TT, et al. 2021. JCI Insight. 6:. PubMed
  127. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  128. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  129. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  130. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  131. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  132. Zheng J, et al. 2020. Nature. . PubMed
  133. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  134. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  135. Gough D, et al. 2014. Blood. 124:2252. PubMed
  136. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  137. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  138. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  139. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  140. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  141. Giampazolias E, et al. 2021. Cell. . PubMed
  142. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  143. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  144. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  145. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  146. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  147. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  148. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  149. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  150. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  151. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  152. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  153. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  154. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  155. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  156. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  157. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  158. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  159. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  160. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  161. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  162. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  163. Koide S, et al. 2022. iScience. 25:103603. PubMed
  164. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  165. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  166. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  167. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  168. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  169. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  170. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  171. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  172. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  173. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  174. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  175. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  176. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  177. Li H, et al. 2022. iScience. 25:104481. PubMed
  178. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  179. Zhang B, et al. 2021. Nature. 599:471. PubMed
  180. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  181. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  182. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  183. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  184. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  185. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  186. Yang H, et al. 2022. Viruses. 14:. PubMed
  187. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  188. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  189. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  190. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  191. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  192. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  193. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  194. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  195. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  196. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  197. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  198. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  199. Duhalde Vega M, et al. 2022. Sci Adv. 8:eabn6545. PubMed
  200. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  201. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  202. Zhu S, et al. 2023. Theranostics. 13:1042. PubMed
  203. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  204. Agrafiotis A, et al. 2023. iScience. 26:106055. PubMed
  205. Ke F, et al. 2023. Elife. 12:. PubMed
  206. Tursi NJ, et al. 2023. Front Immunol. 14:1072810. PubMed
  207. Rege SV, et al. 2023. Commun Biol. 6:292. PubMed
  208. Battistello E, et al. 2023. Mol Cell. 83:1216. PubMed
  209. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  210. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  211. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  212. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  213. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  214. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  215. Apte SH, et al. 2020. Clin Transl Immunology. 9:e1209. PubMed
  216. Collin R, et al. 2020. J Immunol. 205:133. PubMed
  217. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  218. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  219. Chan WY, et al. 2022. Infect Immun. 90:e0084618a. PubMed
  220. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  221. Qu L, et al. 2022. Cell. 185:1728. PubMed
  222. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  223. Kiani Shabestari S, et al. 2022. Cell Rep. 39:110961. PubMed
  224. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  225. Yu Z, et al. 2022. Biomater Sci. 11:263. PubMed
  226. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  227. Zhao K, et al. 2023. Front Immunol. 14:1101769. PubMed
  228. Azevedo PO, et al. 2023. NPJ Vaccines. 8:15. PubMed
  229. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  230. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  231. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  232. Elazar A, et al. 2022. Elife. 11:. PubMed
  233. Berube A, et al. 2022. Viruses. 14:. PubMed
  234. Kastenmüller K, et al. 2013. Infect Immun . 81:789. PubMed
  235. Quinn K, et al. 2013. J Immunol. 191:5085. PubMed
  236. Chuang H, et al. 2014. Nat Commun. 5:4602. PubMed
  237. Cabrera-Mora M, et al. 2016. J Immunol. 197: 2748 - 2761. PubMed
  238. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  239. Chen J, et al. 2008. Blood. 111:5163. PubMed
  240. Fu Z, et al. 2019. Cell Rep. 28:159. PubMed
  241. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  242. Romain Bouziat et al. 2018. Cell host & microbe. 24(5):677-688 . PubMed
  243. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  244. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  245. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  246. Hirako I, et al. 2016. Nat Commun. 7:13277. PubMed
  247. Singhal A, et al. 2014. Sci Transl Med. 6:263. PubMed
  248. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  249. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  250. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  251. Wei H, et al. 2021. Malar J. 20:89. PubMed
  252. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  253. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  254. Park JH, et al. 2022. STAR Protoc. 3:101607. PubMed
  255. Spranger S, et al. 2013. Sci Transl Med. 26:200. PubMed
  256. Sanchez-Felipe L, et al. 2021. Nature. 590:320. PubMed
  257. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  258. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  259. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  260. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  261. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  262. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  263. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  264. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  265. Zhou Y, et al. 2016. Acta Pharmacol Sin. 10.1038/aps.2016.102. PubMed
  266. Lian G et al. 2018. eLife. 7 pii: e36158. PubMed
  267. Das S, et al. 2019. Oncogene. 383316. PubMed
  268. Wei SC, et al. 2019. Immunity. 50:1084. PubMed
  269. Guo X, et al. 2020. Nat Commun. 11:2177. PubMed
  270. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  271. Porsche CE, et al. 2021. JCI Insight. 6:. PubMed
  272. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  273. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  274. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  275. Konrath KM, et al. 2022. Cell Rep. 38:110318. PubMed
  276. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  277. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  278. He C, et al. 2020. Clin Transl Med. 10:e39. PubMed
  279. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  280. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  281. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  282. Zhang X, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:494. PubMed
  283. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  284. Nagarajan D, et al. 2021. Immunol Cell Biol. 99:972. PubMed
  285. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  286. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  287. Marangoni F, et al. 2021. Cell. . PubMed
  288. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  289. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  290. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  291. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  292. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  293. Hiltensperger M, et al. 2021. Nat Immunol. 22:880. PubMed
  294. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  295. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  296. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  297. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  298. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
  299. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  300. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  301. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  302. Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed
  303. Muñoz NM, et al. 2022. Sci Rep. 12:14449. PubMed
  304. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  305. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  306. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  307. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  308. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  309. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  310. O'Brien S, Zhang M 2015. J Immunol. 195: 695-705. PubMed
  311. Zheng J, et al. 2020. bioRxiv. . PubMed
  312. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  313. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  314. Zhang C, et al. 2020. Cell Rep. 32:108206. PubMed
  315. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  316. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  317. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  318. Fu Z, et al. 2021. Nat Commun. 12:4462. PubMed
  319. França TT, et al. 2021. JCI Insight. 6:. PubMed
  320. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  321. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  322. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  323. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  324. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  325. Zheng J, et al. 2020. Nature. . PubMed
  326. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  327. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  328. Gough D, et al. 2014. Blood. 124:2252. PubMed
  329. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  330. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  331. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  332. Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed
  333. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  334. Giampazolias E, et al. 2021. Cell. . PubMed
  335. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  336. Martin MD, et al. 2020. Cell Rep. 31:107508. PubMed
  337. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  338. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  339. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  340. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  341. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  342. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  343. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  344. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  345. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  346. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  347. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  348. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  349. Fang Y, et al. 2021. J Clin Invest. 131:00:00. PubMed
  350. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  351. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  352. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  353. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  354. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  355. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  356. Koide S, et al. 2022. iScience. 25:103603. PubMed
  357. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  358. Shoji M, et al. 2012. PLoS One. 7:e30302. PubMed
  359. Pradhan K, et al. 2021. J Immunol. 206:2980. PubMed
  360. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  361. Neckermann P, et al. 2021. Front Immunol. 12:761214. PubMed
  362. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  363. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  364. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  365. Chew HY, et al. 2020. Cell. 180(5):895-914. PubMed
  366. Lavoie S, et al. 2020. Gastroenterology. 158:1359. PubMed
  367. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  368. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  369. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  370. Li H, et al. 2022. iScience. 25:104481. PubMed
  371. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  372. Zhang B, et al. 2021. Nature. 599:471. PubMed
  373. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  374. Yang FM, et al. 2022. Front Immunol. 13:918241. PubMed
  375. Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
  376. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  377. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  378. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  379. Yang H, et al. 2022. Viruses. 14:. PubMed
  380. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  381. Li H, et al. 2021. Signal Transduct Target Ther. 6:389. PubMed
  382. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  383. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  384. Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
  385. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  386. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
RRID
AB_312753 (BioLegend Cat. No. 100714)
AB_312752 (BioLegend Cat. No. 100713)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
FITC anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 3    Revision Date: 01.30.2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account